Valiglurax
| CAS No. | 1976050-09-5 | Cat. No. | BCP34233 |
| Name | Valiglurax | ||
| Synonyms | VU2957; VU-2957; VU 2957; VU0652957; VU-0652957; VU 0652957; | ||
| Formula | C16H10F3N5 | M. Wt | 329.28 |
| Description | Valiglurax is a potent, selective, CNS penetrant, and orally bioavailable mGlu4 PAM. VU2957 possessed attractive in vitro and in vivo pharmacological and DMPK properties across species. VU2957 was evaluated as a preclinical development candidate for the treatment of Parkinson’s disease. | ||
| Pathways | GPCR/G Protein | ||
| Targets | mGluR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.